Losartan Potassium Oral Suspension (Scienture)

氯沙坦钾口服混悬剂 (Scienture)

Report date: 2025/04/20 20:00:03

Base Information

Drug NameLosartan Potassium Oral Suspension (Scienture)
Drug Alias NameArbliSCN-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/03/13
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesScienture LLC
China Registration ClassN/A

Develop Information

Active CompaniesScienture LLC
Inactive CompaniesScienture Inc
Active IndicationsHypertension
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A